Accurate Clinical Research, Inc

The trials here

What the 13 trials at this site are about, from their registry records.

Conditions

• Rheumatoid arthritis6 trials
• Lupus (SLE)3 trials
• Obesity2 trials
• Psoriasis2 trials
• Psoriatic arthritis2 trials
• Osteoarthritis1 trial
• Sjögren's disease1 trial

Phase

• Phase 26 trials
• Phase 34 trials
• Phase 42 trials
• Phase 11 trial

Status

• Recruiting5 trials
• Active, not recruiting4 trials
• Completed3 trials
• Terminated1 trial

Lead sponsor

• Eli Lilly and Company4 trials
• Hoffmann-La Roche2 trials
• Aurinia Pharmaceuticals Inc.1 trial
• Biogen1 trial
• Gilead Sciences1 trial
• and 4 more

Running trials

• Recruiting

  An Extension Study to Assess Long-Term Safety and Efficacy of Afimkibart in Participants With Rheumatoid Arthritis

  NCT07620392· Phase 2· Hoffmann-La Roche· Source

• Recruiting

  PRESERVE: LUPKYNIS in Combination With Belimumab, Obinutuzumab or Anifrolumab in Patients With Lupus Nephritis

  NCT07611214· Phase 4· Aurinia Pharmaceuticals Inc.· Source

• Recruiting

  A Study of Nipocalimab in Adults With Moderate to Severe Systemic Lupus Erythematosus

  NCT07438496· Phase 3· Janssen Research & Development, LLC· Source

• Recruiting

  Phase 3 Study of Telitacicept in Active Primary Sjögren's Disease

  NCT07404865· Phase 3· Vor Biopharma· Source

  Contact: Jeremy Sokolove

• Recruiting

  A Study to Assess the Efficacy and Safety of RO7790121 in Participants With Moderate to Severe Rheumatoid Arthritis Who Have Not Responded to or Who Cannot Tolerate Tumor Necrosis Factor (TNF) and/or Janus Kinase (JAK Inhibitors)

  NCT07137598· Phase 2· Hoffmann-La Roche· Source

• Active, not recruiting

  Study of GS-0151 in Participants With Rheumatoid Arthritis

  NCT06902519· Phase 1· Gilead Sciences· Source

• Active, not recruiting

  53-Week Study Evaluating the Safety and Efficacy of Intra-articular Injections of TPX-100 With Mild to Severe Tibio-Femoral Osteoarthritis of the Knee

  NCT06865079· Phase 2· OrthoTrophix, Inc· Source

• Active, not recruiting

  A Study to Investigate Effectiveness of Tirzepatide Following Initiation of Ixekizumab in Participants With Active Psoriatic Arthritis and Overweight or Obesity in Clinical Practice (TOGETHER AMPLIFY-PsA)

  NCT06864026· Phase 4· Eli Lilly and Company· Source

• Active, not recruiting

  A Study to Learn About the Safety of Litifilimab (BIIB059) Injections and Whether They Can Improve Symptoms of Adult Participants Who Have Systemic Lupus Erythematosus

  NCT04895241· Phase 3· Biogen· Source

Recruiting at the same time

How many trials recruit for the same indication here at once. A count, not a rating.

• Lupus (SLE)2 recruiting
• Rheumatoid arthritis2 recruiting
• Sjögren's disease1 recruiting

Closed trials

• Terminated

  A Study of LY3541860 in Adult Participants With Moderately to Severely Active Rheumatoid Arthritis

  NCT06859294· Phase 2· Eli Lilly and Company· Source

• Completed

  Ixekizumab Concomitantly Administered With Tirzepatide in Adults With Psoriatic Arthritis and Obesity or Overweight

  NCT06588296· Phase 3· Eli Lilly and Company· Source

• Completed

  Natrunix or Placebo in Combination With Methotrexate in Rheumatoid Arthritis

  NCT05363891· Phase 2· XBiotech, Inc.· Source

• Completed

  An Adaptive Phase 2a/2b Study of LY3871801 in Adult Participants With Rheumatoid Arthritis

  NCT05848258· Phase 2· Eli Lilly and Company· Source